USER FOCUS
At Haselmeier, our mission is to create products enabling a convenient and comfortable experience. This is why patient feedback is integrated early in our device designs. Early concepts are prototyped for testing and Human Factors studies to capture the handling needs and skills of potential users. This knowledge is integrated into the device design to provide successful administration of the drug product and a positive user experience.

BRIDGE TO MARKET
Successful development and industrialization of drug delivery devices is dependent upon the understanding and execution of today’s technical, regulatory and operational requirements. At Haselmeier we provide integrated design, development and industrialization services to help you bridge your serial product into the market. Our qualified design control process, certified quality system, regulatory expertise, solid network of partners and strong manufacturing operations are all designed to achieve your expectations. Together we enable a smooth market introduction for your commercial drug delivery device. 

MANUFACTURING & LIFECYCLE PARTNER
We understand that each customer has individual and specific requirements for their product. Regardless of your requirements, Haselmeier applies the highest quality standard for manufacturing your drug delivery device to ensure a reliable and reproducible manufacturing and quality process. We work continuously with our customers to identify product improvements at all stages of the product’s lifecycle to provide a safe and state-of-the art drug delivery device.

Drug Delivery. Tailormade.

Advertorial

Go to article: Home | A New Class of TreatmentGo to article: EditorialGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: DistekGo to article: The pharma industry briefingGo to article: DelSiTechGo to article: Big soil: A $1bn project to develop new drugs from earthGo to article: Novo NordiskGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: medical hempGo to article: Cannabinoids breakthrough signals hope for epilepsy treatment Go to article: CBDepot Company InsightGo to article: CBDepotGo to article: Capsugel Company InsightGo to article: Could cutting out mediators let cancer research off the leash? Go to article: EcocoolGo to article: The next generation of antimalarials Go to article: AlpexGo to article:  Pharma air freight: what does it take to get certified? Go to article: PangeanicGo to article: Blocking generic competition: will naming and shaming work?Go to article: Haselmeier GmbH Company InsightGo to article: Haselmeier GmbH Go to article: EventsGo to article: Abiogen PharmaGo to article: Next issueGo to article: HOF SonderanlagenbauGo to article: EvolveGo to article: ILC Dover Inc